These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35868306)

  • 21. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
    Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
    Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
    Lai Y; Sheng L; Wang J; Zhou M; OuYang G
    Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia.
    Lee JE; Kwon CS; Jeon BE; Kim WR; Lee DH; Koh S; Kim HS; Kim SW
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).
    Lu L; Wen Y; Yao Y; Chen F; Wang G; Wu F; Wu J; Narayanan P; Redell M; Mo Q; Song Y
    Theranostics; 2018; 8(8):2189-2201. PubMed ID: 29721072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel analogs of 1,25-dihydroxyvitamin D
    Nachliely M; Sharony E; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.
    Eide CA; Kurtz SE; Kaempf A; Long N; Agarwal A; Tognon CE; Mori M; Druker BJ; Chang BH; Danilov AV; Tyner JW
    Leukemia; 2020 Sep; 34(9):2342-2353. PubMed ID: 32094466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells.
    Yong SB; Chung JY; Kim SS; Choi HS; Kim YH
    Biomaterials; 2020 Feb; 230():119651. PubMed ID: 31787334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.
    Beck D; Thoms JAI; Palu C; Herold T; Shah A; Olivier J; Boelen L; Huang Y; Chacon D; Brown A; Babic M; Hahn C; Perugini M; Zhou X; Huntly BJ; Schwarzer A; Klusmann JH; Berdel WE; Wörmann B; Büchner T; Hiddemann W; Bohlander SK; To LB; Scott HS; Lewis ID; D'Andrea RJ; Wong JWH; Pimanda JE
    Leukemia; 2018 Feb; 32(2):263-272. PubMed ID: 28674423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A precision medicine classification for treatment of acute myeloid leukemia in older patients.
    Mims AS; Kohlschmidt J; Borate U; Blachly JS; Orwick S; Eisfeld AK; Papaioannou D; Nicolet D; Mrόzek K; Stein E; Bhatnagar B; Stone RM; Kolitz JE; Wang ES; Powell BL; Burd A; Levine RL; Druker BJ; Bloomfield CD; Byrd JC
    J Hematol Oncol; 2021 Jun; 14(1):96. PubMed ID: 34162404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies.
    Tayari MM; Santos HGD; Kwon D; Bradley TJ; Thomassen A; Chen C; Dinh Y; Perez A; Zelent A; Morey L; Cimmino L; Shiekhattar R; Swords RT; Watts JM
    Clin Cancer Res; 2021 Apr; 27(7):1893-1903. PubMed ID: 33495312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
    Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
    Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
    Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
    Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
    Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.
    Brendel C; Teichler S; Millahn A; Stiewe T; Krause M; Stabla K; Ross P; Huynh M; Illmer T; Mernberger M; Barckhausen C; Neubauer A
    PLoS One; 2015; 10(4):e0123181. PubMed ID: 25901794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression.
    Liu L; Liu H; Liu L; Huang Q; Yang C; Cheng P; Ren S; Zhang J; Yu M; Ma X; Song W; Chen L; Zhang H; Chen M; Zhang X
    Cancer Biol Ther; 2023 Dec; 24(1):2228497. PubMed ID: 37381175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networks.
    Rücker FG; Lang KM; Fütterer M; Komarica V; Schmid M; Döhner H; Schlenk RF; Döhner K; Knudsen S; Bullinger L
    Epigenetics; 2016 Jul; 11(7):517-25. PubMed ID: 27309669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic genes in the acute myeloid leukemia microenvironment.
    Huang S; Zhang B; Fan W; Zhao Q; Yang L; Xin W; Fu D
    Aging (Albany NY); 2019 Nov; 11(22):10557-10580. PubMed ID: 31740623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway.
    Ling Q; Li F; Zhang X; Mao S; Lin X; Pan J; Ye W; Wei W; Qian Y; Hu C; Huang X; Wang J; Wang H; Huang J; Wang Y; Jin J
    EBioMedicine; 2021 Jul; 69():103441. PubMed ID: 34166980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.